Nick Bird

ORCID: 0000-0003-1808-8584
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroblastoma Research and Treatments
  • Childhood Cancer Survivors' Quality of Life
  • Pharmaceutical studies and practices
  • Cancer therapeutics and mechanisms
  • CAR-T cell therapy research
  • Lung Cancer Research Studies
  • Alzheimer's disease research and treatments
  • Pain Mechanisms and Treatments
  • Peroxisome Proliferator-Activated Receptors
  • Acute Lymphoblastic Leukemia research
  • Pain Management and Placebo Effect
  • Cardiac electrophysiology and arrhythmias
  • Folate and B Vitamins Research
  • Ion Channels and Receptors
  • Atrial Fibrillation Management and Outcomes
  • Cancer, Hypoxia, and Metabolism
  • Protein Degradation and Inhibitors
  • Plant-based Medicinal Research
  • Venomous Animal Envenomation and Studies
  • Diabetic Foot Ulcer Assessment and Management
  • Metabolism and Genetic Disorders
  • Ethics and Legal Issues in Pediatric Healthcare
  • Asthma and respiratory diseases
  • Dementia and Cognitive Impairment Research
  • Ethics in Clinical Research

London Cancer
2021-2025

GlaxoSmithKline (United Kingdom)
2002-2021

Age UK
2021

National Cancer Research Institute
2020

Current treatments of neuropathic pain arising from conditions such as nerve injury/compression are only partially effective, and limited in their use by side-effects. p38 mitogen-activated protein kinase (MAPK) is involved the regulation synthesis inflammatory mediators, target for a novel class cytokine-suppressive anti-inflammatory drugs. inhibitors may reduce neuronal sensitisation preclinical models pain, particularly where there substantial component. An exploratory, multicentre,...

10.1016/j.ejpain.2011.04.005 article EN European Journal of Pain 2011-05-22

The SARS-Cov-2 (COVID-19) pandemic remains a major worldwide public health issue. Initially, improved supportive and anti-inflammatory intervention, often employing known drugs or technologies, provided measurable improvement in management. We have recently seen advances specific therapeutic interventions vaccines. Nevertheless, it will be months before most of the world’s population can vaccinated to achieve herd immunity. In interim, hyperbaric oxygen (HBO2) treatment offers several...

10.22462/01.03.2021.1 article EN Undersea and Hyperbaric Medicine 2021-01-01

Airway sensory nerves involved in the cough reflex are activated by adenosine triphosphate (ATP) agonism of P2X purinoceptor 3 (P2X3) receptors. Transient receptor potential vanilloid 4 (TRPV4) channel activation causes ATP release from airway cells, and it is hypothesised that a TRPV4-ATP-P2X3 axis contributes to chronic cough. An adaptive study was run determine if TRPV4 inhibition, using selective blocker GSK2798745, effective reducing cough.A two-period randomised, double blinded,...

10.1183/23120541.00269-2021 article EN cc-by-nc ERJ Open Research 2021-06-17

Abstract Background More effective incentives are needed to motivate paediatric oncology drug development, uncoupling it from dependency on adult development. Although the current European and North‐American legislations aim promote development for paediatrics rare diseases, children adolescents with cancer have not benefited as expected these initiatives remains first cause of death by disease in older than one. Drug childhood dependent indications their potential market. The balance...

10.1002/cam4.5627 article EN cc-by Cancer Medicine 2023-01-16

High-dose chemotherapy with autologous stem cell transplant (ASCT) has been a mainstay of high-risk neuroblastoma treatment for several decades, demonstrating improvements in event-free survival but risks serious or even life-threatening acute toxicities, severe long-term adverse health effects survivors, and ongoing contention regarding overall benefit. The merits ASCT the modern era immunotherapy are source debate among parents, advocates, some physicians. Here we examine evidence against...

10.1002/pbc.29663 article EN Pediatric Blood & Cancer 2022-04-04

Importance In poor-prognosis children’s cancers, new therapies may carry fresh hope for patients and parents. However, there is an absolute requirement any therapy to be properly evaluated fulfill scientific, regulatory, reimbursement requirements. Randomized clinical trials (RCTs) are considered the gold standard, but no consensus exists on how when they should deployed best meet needs of all stakeholders. Objective To conduct a multistakeholder meeting foster greater shared understanding...

10.1001/jamanetworkopen.2024.49239 article EN cc-by-nc-nd JAMA Network Open 2024-12-06

Alzheimer's Disease (AD) leads to a progressive reduction of brain metabolism, which correlates with disease severity and is detectable 18F-FDG PET, Rosiglitazone was demonstrated have favorable effect on cognitive function in AD1, 2. We assessed the effects rosiglitazone metabolism over 12-month period pilot double-blind, placebo controlled, randomized parallel group study. Eighty patients mild-to-moderate AD (MMSE 16-23) were 1:1 ratio receive daily dose either (8 mg extended release), or...

10.1016/j.jalz.2009.05.642 article EN Alzheimer s & Dementia 2009-06-25

Abstract A diverse range of non‐cardiovascular drugs are associated with QT interval prolongation, which may be a potentially fatal ventricular arrhythmia known as torsade de pointes. has been assessed for two recent submissions at GlaxoSmithKline. Meta‐analyses ECG data from several clinical pharmacology studies were conducted the submissions. general fixed effects meta‐analysis approach using summaries individual was used to calculate pooled estimate and 90% confidence difference between...

10.1002/pst.3 article EN Pharmaceutical Statistics 2002-06-01

Alzheimer's Disease (AD) leads to a progressive reduction of brain metabolism, which correlates with disease severity and is detectable 18F-FDG PET, Rosiglitazone was demonstrated have favorable effect on cognitive function in AD 1., 2.. We assessed the effects rosiglitazone metabolism over 12-month period pilot double-blind, placebo controlled, randomized parallel group study. Eighty patients mild-to-moderate (MMSE 16-23) were 1:1 ratio receive daily dose either (8 mg extended release), or...

10.1016/j.jalz.2009.04.117 article EN Alzheimer s & Dementia 2009-06-25
Coming Soon ...